The Dow advanced 0.46 percent to 34,792.90 at the close of business on Friday, while the NASDAQ gained 0.67 percent to 14,619.12. The S&P 500 increased 0.66 percent to 4,348.47.
The United States has the largest number of coronavirus cases and deaths in the world, with 33,680,520 infections and 605,030 deaths reported. India recorded at least 30,458,250 cases and 400,310 deaths, while Brazil reported around 18,622,300 cases and 520,090 deaths. According to data provided by Johns Hopkins University, there were at least 182,685,990 cases of COVID-19 worldwide, with more than 3,956,750 deaths.

Sectors that are leading and those that are lagging

On Friday, shares of information technology rose 1.2 percent. Marin Software Incorporated (NASDAQ: MRIN), up 38 percent, and Cerence Inc. (NASDAQ: CRNC), up 16 percent, were among the sector’s top gainers.

Energy stocks declined 0.2 percent in Friday’s session.

Headline 1:
In June, the US economy added 850,000 jobs, the highest level of job creation in ten months. In June, the unemployment rate in the United States increased to 5.9%.
Equities are rising in value.

The stock of Eco Wave Power Global AB (NASDAQ: WAVE) jumped 79 percent to $19.43. Alpha Capital owns 8.7% of the company, according to a 13G filing.

Alector, Inc. (NASDAQ: ALEC) had its stock rise by 53 percent to $34.37. Alector and GlaxoSmithKline have formed a global partnership to develop and commercialize two monoclonal antibodies to raise progranulin (PGRN) levels.

TAT Technologies Ltd. (NASDAQ: TATT) gained 39 percent to $8.21 following the announcement of a new MRO partnership with Honeywell.

Take a look at today’s big movers.

Trading in equities is down.
After receiving a letter from the FDA addressing the sulopenem etzadroxil/probenecid marketing application review for uncomplicated urinary tract infections, Iterum Therapeutics plc (NASDAQ: ITRM) shares fell 38% to $1.4167. At this time, the agency has discovered shortcomings that prevent discussion of labeling and post-marketing requirements/commitments.
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has voluntarily paused the AROENaC1001 Phase 1/2 research testing ARO-ENaC for cystic fibrosis. After obtaining a preliminary update from an ongoing chronic toxicology investigation in rats, which revealed unexpected evidence of local lung inflammation, the decision was made.
The stock of Alterity Therapeutics Limited (NASDAQ: ATHE) went down 21% to $1.69. A proposed offering of 322,857,900 shares was disclosed in an Alterity Therapeutics Australia document. On Thursday, Alterity Therapeutics’ stock rose over 65 percent after the firm revealed it had been given a new US patent that targets key neurological illnesses such as Alzheimer’s and Parkinson’s.

Commodities

Oil fell 0.1 percent to $75.18 per barrel, while gold rose 0.8 percent to $1,790.90 per ounce.

Silver surged 2.1 percent to $26.645 on Friday, while copper gained 1.3 percent to $4.2920.

The Eurozone
Today’s European stock market close was mixed. The STOXX 600 index in the eurozone rose 0.26 percent, while the Spanish Ibex Index lost 0.28 percent and the German DAX 30 rose 0.3 percent. Meanwhile, the FTSE 100 in London declined 0.03 percent, the CAC 40 in France fell 0.01 percent, and the FTSE MIB in Italy fell 0.01 percent.
In January-May, the French government’s budget deficit increased marginally to EUR 118.8 billion, up from EUR 117.9 billion the previous year. Spain’s jobless rate fell from 3.61 million in May to 166,911 in June.

Economics

In June, the US economy added 850,000 jobs, the highest level of job creation in ten months. In June, the unemployment rate in the United States increased to 5.9%.

In May, the trade gap grew to $71.2 billion, up from $69.1 billion the previous month.

Following a revised 0.1 percent decline in April, factory orders in the United States increased by 1.7 percent in May.

Baker Hughes Inc said that the total number of active U.S. oil rigs increased by four this week to 376.
Here is a link to the complete economic calendar.
(c) Benzinga.com, 2021. Benzinga does not offer financial advice. All intellectual property rights are reserved./nRead More